Cargando…

Model for Assessing Human Papillomavirus Vaccination Strategies

We present a transmission dynamic model that can assess the epidemiologic consequences and cost-effectiveness of alternative strategies of administering a prophylactic quadrivalent (types 6/11/16/18) human papillomavirus (HPV) vaccine in a setting of organized cervical cancer screening in the United...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elbasha, Elamin H., Dasbach, Erik J., Insinga, Ralph P.
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725801/ https://www.ncbi.nlm.nih.gov/pubmed/17370513 http://dx.doi.org/10.3201/eid1301.060438

Ejemplares similares

Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model
por: Insinga, Ralph P, et al.
Publicado: (2009)

Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women
por: Insinga, Ralph P, et al.
Publicado: (2007)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach
por: Hayajneh, Wail A., et al.
Publicado: (2018)

Correction to: Public health impact and cost effectiveness of routine childhood vaccination for hepatitis a in Jordan: a dynamic model approach
por: Hayajneh, Wail A., et al.
Publicado: (2019)

Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study
por: Cody, Palmer, et al.
Publicado: (2021)

Vaccination and herd immunity thresholds in heterogeneous populations
por: Elbasha, Elamin H., et al.
Publicado: (2021)

Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches
por: Elbasha, Elamin H.
Publicado: (2022)

Human Papillomavirus Vaccination Strategies
por: Cachafeiro, Santiago Pérez
Publicado: (2007)

Therapeutic Vaccine Strategies against Human Papillomavirus
por: Khallouf, Hadeel, et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Routine Use of 15-Valent Pneumococcal Conjugate Vaccine in the US Pediatric Population
por: Huang, Min, et al.
Publicado: (2023)

Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance
por: Nygård, Mari, et al.
Publicado: (2014)

1097 Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Yang, H. Keri, et al.
Publicado: (2014)

Modeling Cervical Cancer Screening Strategies With Varying Levels of Human Papillomavirus Vaccination
por: Grimes, David Robert, et al.
Publicado: (2021)

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland
por: French, K M, et al.
Publicado: (2007)

Appropriate human papillomavirus vaccination strategies – Authors' reply
por: Michels, Karin B, et al.
Publicado: (2009)

A primer on using mathematics to understand COVID-19 dynamics: Modeling, analysis and simulations
por: Gumel, Abba B., et al.
Publicado: (2020)

Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States
por: Daniels, Vincent, et al.
Publicado: (2021)

Modeling the Impact of Exogenous Boosting and Universal Varicella Vaccination on the Clinical and Economic Burden of Varicella and Herpes Zoster in a Dynamic Population for England and Wales
por: Sharomi, Oluwaseun, et al.
Publicado: (2022)

Is human papillomavirus vaccination likely to be a useful strategy in India?
por: Gupta, Sudeep, et al.
Publicado: (2013)

Vaccine Strategies for Human Papillomavirus-Associated Head and Neck Cancers
por: Zhou, Jade Z., et al.
Publicado: (2021)

Comment on “Safety of Human Papillomavirus Vaccines: An Updated Review”
por: Chandler, Rebecca Ellen, et al.
Publicado: (2018)

Evaluating Human Papillomavirus Vaccination Programs
por: Taira, Al V., et al.
Publicado: (2004)

Cost-Effectiveness of Pneumococcal Vaccines for Adults in the United States
por: Chen, Jieling, et al.
Publicado: (2014)

Human papillomavirus vaccine
por: Singhal, Priyanka, et al.
Publicado: (2009)

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study
por: Matthijsse, Suzette M., et al.
Publicado: (2018)

Computational modeling of human papillomavirus with impulsive vaccination
por: Berhe, Hailay Weldegiorgis, et al.
Publicado: (2021)

Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
por: Sundaram, Maria E., et al.
Publicado: (2022)

A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada
por: Insinga, Ralph P., et al.
Publicado: (2016)

Geospatial patterns of human papillomavirus vaccine uptake in Minnesota
por: Nelson, Erik J, et al.
Publicado: (2015)

Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model
por: Baussano, Iacopo, et al.
Publicado: (2014)

Quality Assessment of Websites Providing Information on Human Papillomavirus Vaccines in Thailand
por: Likitdee, Naratassapol, et al.
Publicado: (2019)

Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students
por: Deriemaeker, Hanne, et al.
Publicado: (2014)

Vaccination against human papillomavirus
por: Mello, Claudia Figueiredo
Publicado: (2013)

Human papillomavirus vaccination strategies for accelerating action towards cervical cancer elimination
por: Shet, Anita, et al.
Publicado: (2023)

Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2017)

Knowledge of Cervical Cancer and Acceptability of Prevention Strategies Among Human Papillomavirus-Vaccinated and Human Papillomavirus-Unvaccinated Adolescent Women in Eldoret, Kenya
por: Mburu, Anisa, et al.
Publicado: (2019)

Human papillomavirus: The disease and prevention strategies
por: Akhtar, Mohammed
Publicado: (2004)

Adolescent Male Human Papillomavirus Vaccination
por: Nanagas, Vivian C., et al.
Publicado: (2016)

Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pbsjidjbe30c848rdpsq4onvlo